Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Subtilisin Carlsberg is a well-studied bacterial serine protease and a member of the subtilase (serine protease) family S8, known for its broad substrate specificity and high activity at alkaline pH[3][1][8][2][4]. It is secreted by certain Bacillus species, notably Bacillus licheniformis and Bacillus subtilis, as a 275-amino acid globular protein that uses a classic serine protease catalytic triad (Asp-32, His-64, Ser-221) for hydrolysis of peptide bonds[6][5][1]. Its primary biological role is nutrient acquisition for bacteria via extracellular protein degradation, and it is extensively utilized as an industrial enzyme (for example, in laundry detergents, leather processing, and food industry)[2][3]. Subtilisin Carlsberg is not a biomolecular therapeutic target in humans or animals, nor is it a receptor, transporter, or disease-associated biomolecule; thus, it is not targeted by drugs, and it is not used for diagnostic or therapeutic biomarker purposes.
Hydrolysis of peptide bonds via serine protease catalytic triad (Asp-His-Ser)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Subtilisin Carlsberg.